Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
COVID-19 News: LRRC15 And SARS-CoV-2  Feb 10, 2023  1 year, 2 weeks, 12 hours, 11 minutes ago

COVID-19 News: Article In The Guardian About Australians Now Discovering the SARS-CoV-2 Receptor Protein LRRC15 Is Misleading! (FACT CHECKED)

4319 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: Article In The Guardian About Australians Now Discovering the SARS-CoV-2 Receptor Protein LRRC15 Is Misleading! (FACT CHECKED)
COVID-19 News: LRRC15 And SARS-CoV-2  Feb 10, 2023  1 year, 2 weeks, 12 hours, 11 minutes ago
COVID-19 News: No sure who is paying the Guardian or whether some of their coverages are being paid by those controlling the COVID-19 narratives to deflect the concerns about the current COVID-19 situation and the potential threats that are brewing or to provide false hopes to the ignorant masses, but their article today that was written to make it look like some new major discovery in SARS-CoV-2 research by Australian researchers is basically old news and the discovery itself has not lead to any new developments since November 2021 when the Australian researchers first published their study findings.
https://www.theguardian.com/australia-news/2023/feb/09/crazy-interesting-findings-by-australian-researchers-may-reveal-key-to-covid-immunity


 
The Australian researchers from University of Sydney along with medical scientists from Switzerland had conducted the study in late 2021 and published a preprint about the study findings in November 2021 as covered by our past COVID-19 News coverages.
 
https://www.thailandmedical.news/news/breaking-university-of-sydney-study-discovers-a-new-receptor-lrrc15-that-binds-with-sars-cov-2-and-suppresses-infection-and-regulates-fibrosis
 
The study findings showed that a protein in the lungs called LRRC15 was also a SARS-CoV-2 receptor (ie able to bind to the virus) and was able to suppress infections and also regulate fibrosis.
 
In fact, the discovery of LRRC15 and its role in SARS-CoV-2 infections was actually discovered earlier by researchers from the United Kingdom and Germany and their study was published as a preprint in September 2021.
https://www.thailandmedical.news/news/breaking-uk-and-german-scientists-discover-that-protein-lrrc15-interaction-with-sars-cov-2-spike-protein-could-be-modulating-infection
 
The British and German researchers had been researching in this area and the role of LRRC15 in supressing SARS-CoV-2 since late 2020 and the Australian researchers had seen that preprint prior to their own published study!
 
Another team from America comprising of researchers from Yale and Brown University had also been working on LRRC15 and SARS-CoV-2 research since March 2021 and had published their study findings also in a preprint version in November 2021, 3 days after the Australian researchers had published their though the Americans had submitted their study findings much earlier to the preprint server!
https://www.biorxiv.org/content/10.1101/2021.11.23.469714v1
 
The Guardian article made it look as if it was the Australian researchers that had made this di scovery and also made the discovery only now.
 
While the British, German and American researchers are not the least interested in disputing any facts or details, writers covering medical and research news should always do due diligence and no simply work from Press Releases issued to then especially if they are health or medical writers!
https://www.sydney.edu.au/news-opinion/news/2023/02/10/scientists-discover-receptor-that-blocks-covid-19-infection.html
 
There are also other British researchers who have been working on LRRC15 and SARS-CoV-2 research.
https://www.medrxiv.org/content/10.1101/2022.04.29.22274267v1.full
 
The Australian team to date have not progressed in any way with their study findings whereas the British, German and American team have already made drugs with nanoparticles simulating these LRRC15 proteins to suppress SARS-CoV-2 infections and have also further explored ways to upregulate genes that can stimulate LRCC15 production in the host body. A number of animal studies have already been concluded since.

Also note that newer preliminary data indicates that not all the newer emerging SARS-CoV-2 subvariants and sub-lineages bind to the LRRC15 proteins!
 
For the latest credible COVID-19 News, keep on logging to Thailand Medical News.
 
 
 
 

MOST READ

Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19
Apr 26, 2020  4 years ago
Source: COVID-19 Research